Finance

NewTimeSpace (newtimespace.com) News, August 31, 2026, NOIZ GROUP(08163.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at HKD 7.62 million, decreased by 19.88% YoY

2026-09-01

NewTimeSpace (newtimespace.com) News, August 31, 2026, CMBC CAPITAL(01141.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at HKD 302.02 million, increased by 10.54% YoY

2026-09-01

NewTimeSpace (newtimespace.com) News,August 31, 2026, MAX SIGHT GROUP(08483.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at HKD 17.26 million, decreased by 34.01% YoY

2026-09-01

NewTimeSpace News: On 31 August 2026, VONGROUP (00318.HK) announced that its FY2026 annual results are expected to be published before mid-September 2026, with the despatch of the annual report delayed accordingly; trading in its shares has been suspended since 3 August and will remain suspended until the annual results are published.

2026-09-01

NewTimeSpace News: On 1 September 2026, BIDU-SW (09888.HK) announced that the conversion of its voluntary change from secondary listing to dual-primary listing has taken effect, with the Company now dual-primary listed on the Hong Kong Stock Exchange and the Nasdaq Global Select Market, and its ordinary shares and ADSs remain interchangeable.

2026-09-01

NewTimeSpace News: On 1 September 2026, LAEKNA-B (02105.HK) announced that the first subject has been enrolled in the Phase I clinical study of LAE118, a novel PI3Kα pan-mutation selective inhibitor, for advanced solid tumours in China; the drug has received IND approval from the US FDA and CDE, and in June 2026 the Group entered into an exclusive licence agreement with Vasque Bio providing for payments of up to USD 527 million.

2026-09-01

NewTimeSpace (newtimespace.com) News, August 31, 2026, ASCLETIS-B(01672.HK) released its Interim Report for the period ended December 31, 2026

2026-09-01

NewTimeSpace (newtimespace.com) News, August 31, 2026, VENUS MEDTECH-B(02500.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 135.5 million, decreased by 27.59% YoY

2026-09-01

NewTimeSpace (newtimespace.com) News,August 31, 2026, WK GROUP(02535.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at HKD 87.76 million, decreased by 46.98% YoY

2026-09-01

NewTimeSpace (newtimespace.com) News, August 31, 2026, AGILE GROUP(03383.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 10.86 billion, decreased by 19.99% YoY

2026-09-01

NewTimeSpace (newtimespace.com) News, August 31, 2026, CLOUDBREAK-B(02592.HK) released its Interim Report for the period ended December 31, 2026

2026-09-01

NewTimeSpace (newtimespace.com) News,August 31, 2026, GOLDEN THROAT(06896.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 280.13 million, decreased by 12.25% YoY

2026-09-01

NewTimeSpace News: On 31 August 2026, CSPC PHARMA (01093.HK) announced that the Phase I clinical trial of SYH2092 injection, an amylin receptor agonist for weight management in adults who are overweight or obese, has been formally initiated at the first clinical trial centre in China, following the drug clinical trial approval notice obtained from the National Medical Products Administration in August 2026.

2026-09-01

NewTimeSpace News: On 31 August 2026, WAI CHUN BIOTEC (00660.HK) disclosed further details at the request of the Stock Exchange on its AI data centre project at the Pahang Aerospace City in Malaysia, which will proceed in two phases with Phase 1 expected to take approximately 12 to 36 months to construct and commission; the MOU is not legally binding except for confidentiality and exclusivity provisions, and a formal agreement has yet to be signed.

2026-09-01

NewTimeSpace News: On 31 August 2026, SHEIN-W (00625.HK) announced a final offer price of HKD 48.56 per share for its global offering, with trading to commence on 1 September in board lots of 100 shares; the Hong Kong public offering was 5.63 times subscribed, and net proceeds are approximately HKD 13,214.1 million.

2026-09-01

NewTimeSpace News: On 31 August 2026, SHIFANG HLDG (01831.HK) announced that shares of several shareholder companies were allegedly transferred without authorisation, with the company seals on the transfer documents visibly different from those on file; the Company has reported the matter to the Hong Kong police, and trading in its shares has been suspended since 24 August and will continue to be suspended.

2026-09-01
Previous1..9596 979899..352     352 pages total